Workflow
2025年港股通炒作乱象:药捷安康入通后股价高台跳水 被动资金推涨超2倍后闪崩54% 散户与基民双陷套牢
Xin Lang Zheng Quan·2025-09-30 08:58

Core Insights - The Hong Kong Stock Connect market is undergoing normalization adjustments, with 67 stocks included and 61 stocks removed as of September 30, 2025, raising concerns about the assessment cycle and subsequent price volatility of newly listed stocks [1][6]. Inclusion Rules - Stocks must meet specific criteria to be included in the Hong Kong Stock Connect, including a daily average market capitalization covering the top 95% in the Hong Kong market and passing liquidity tests [2]. Adjustment Timeline - The review dates for adjustments are typically at the end of June and December, with eligible stocks being added to the Hang Seng Composite Index and the Stock Connect in September and March of the following year [3]. Market Manipulation Concerns - Smaller companies with low market capitalization are often targeted for manipulation due to their susceptibility to price movements with minimal capital, leading to two types of speculative activities: collusion between companies and funds, and passive speculation based on index inclusion expectations [5]. Case Study:药捷安康 - After its inclusion in the Stock Connect,药捷安康's stock price surged over 200% before plummeting 54% due to a lack of fundamental support, indicating that speculative trading led to significant losses for retail investors [6][8]. Case Study:曹操出行 - 曹操出行 experienced a 143% price increase post-stabilization period, followed by a sharp decline after its inclusion in the Stock Connect, suggesting potential market manipulation as institutional demand was weak during its IPO [9][10]. Trading Data Insights - Trading data revealed a pattern of accumulation before inclusion and rapid selling afterward, indicating a strategy to profit from retail investors entering the market post-inclusion [10][12].